Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
David M.G. Halpin, Claus F. Vogelmeier, Karen Mezzi, Pritam Gupta, Konstantinos Kostikas, Jadwiga A. Wedzicha

ERJ Open Research Jan 2021, 7 (1) 00816-2020; DOI: 10.1183/23120541.00816-2020
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
Richard W. Chapman, Michel R. Corboz, Carlos Fernandez, Eugene Sullivan, Andy Stautberg, Adam J. Plaunt, Donna M. Konicek, Vladimir Malinin, Zhili Li, David Cipolla, Walter Perkins

ERJ Open Research Jan 2021, 7 (1) 00592-2020; DOI: 10.1183/23120541.00592-2020
First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers
Alison Mackie, Juliane Rascher, Marion Schmid, Verena Endriss, Tobias Brand, Wolfgang Seibold

ERJ Open Research Jan 2021, 7 (1) 00447-2020; DOI: 10.1183/23120541.00447-2020
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Susannah J. King, Dominic Keating, Elyssa Williams, Eldho Paul, Brigitte M. Borg, Felicity Finlayson, Brenda M. Button, John W. Wilson, Tom Kotsimbos

ERJ Open Research Jan 2021, 7 (1) 00203-2020; DOI: 10.1183/23120541.00203-2020
Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study
Jenny Genberg, Joanna M. Davies, Zainab Ahmadi, David Currow, Miriam J. Johnson, Hanan Tanash, Sabrina Bajwah, Magnus Ekström

ERJ Open Research Jan 2021, 7 (1) 00716-2020; DOI: 10.1183/23120541.00716-2020
ICS-formoterol reliever versus ICS and short-acting β₂-agonist reliever in asthma: a systematic review and meta-analysis
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley

ERJ Open Research Jan 2021, 7 (1) 00701-2020; DOI: 10.1183/23120541.00701-2020
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe

ERJ Open Research Jan 2021, 7 (1) 00394-2020; DOI: 10.1183/23120541.00394-2020
The six million dollar man
Mathilde Volpato, Stefan Nowak, Jean Luc Bourrain, Pascal Demoly, Engi Ahmed, Arnaud Bourdin, Jeremy Charriot

ERJ Open Research Jan 2021, 7 (1) 00341-2020; DOI: 10.1183/23120541.00341-2020
Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
Jocelyne Just, Melisande Bourgoin, Flore Amat, Nathalie Cottel, Nathalie Lambert, Stephanie Wanin

ERJ Open Research Oct 2020, 6 (4) 00339-2020; DOI: 10.1183/23120541.00339-2020
An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CF^TM 1
Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne-Caroline Picard, Ming-Chi Hsu, Abhya Gupta, Isabelle Fajac

ERJ Open Research Oct 2020, 6 (4) 00395-2020; DOI: 10.1183/23120541.00395-2020

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us